Search Results - "Mytych DT"

Comparative Study Assessing Multiple Switches Between Biosimilar ABP 501 (adalimumab-atto) and Adalimumab Reference Product in Patients with Plaque Psoriasis.

Authors: Yamauchi PS Chow V Mytych DT et al.

Source: Advances in therapy [Adv Ther] 2026 Jun; Vol. 43 (6), pp. 2795-2808. Date of Electronic Publication: 2026 Apr 09.

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded clinical trial to support interchangeability.

Authors: Blauvelt A Bagel J Pinter A et al.

Source: The British journal of dermatology [Br J Dermatol] 2026 May 29. Date of Electronic Publication: 2026 May 29.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform.

Authors: Grudzinska-Goebel J Benstein K Bloem K et al.

Source: Frontiers in immunology [Front Immunol] 2025 May 22; Vol. 16, pp. 1581153. Date of Electronic Publication: 2025 May 22 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Pharmacokinetic, Safety, and Immunogenicity Similarity of High- and Low-Concentration Formulations of Adalimumab Biosimilar ABP 501, Adalimumab-Atto.

Authors: Chow V Zhou M Mytych DT et al.

Source: Pharmacology research & perspectives [Pharmacol Res Perspect] 2026 Apr; Vol. 14 (2), pp. e70236.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 101626369 Publication Model: Print Cited Medium: Internet ISSN: 2052-1707 (Electronic) Linking ISSN: 20521707 NLM ISO Abbreviation: Pharmacol Res Perspect Subsets: MEDLINE

Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open-Label, Parallel-Group Study.

Authors: Chow V Winkle PJ Mytych DT et al.

Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2026 Feb; Vol. 15 (2), pp. e70031.

Publication Type: Journal Article; Randomized Controlled Trial; Comparative Study

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded active-controlled comparative clinical study over 52 weeks.

Authors: Blauvelt A Papp K Trivedi M et al.

Source: The British journal of dermatology [Br J Dermatol] 2025 Apr 28; Vol. 192 (5), pp. 826-836.

Publication Type: Journal Article; Randomized Controlled Trial; Comparative Study; Multicenter Study

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

Editorial: The immune response to therapeutic antibodies.

Authors: Tovey MG Kromminga AJ Mytych DT

Source: Frontiers in immunology [Front Immunol] 2025 Feb 10; Vol. 16, pp. 1554297. Date of Electronic Publication: 2025 Feb 10 (Print Publication: 2025).

Publication Type: Editorial

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE; In Process

Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria.

Authors: Kulasekararaj A Lanza F Arvanitakis A et al.

Source: American journal of hematology [Am J Hematol] 2024 Nov; Vol. 99 (11), pp. 2108-2117. Date of Electronic Publication: 2024 Aug 22.

Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Comparative Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.

Authors: Kroenke MA Manning MS Zuch de Zafra CL et al.

Source: Frontiers in immunology [Front Immunol] 2024 Jun 20; Vol. 15, pp. 1441999. Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024).

Publication Type: Published Erratum

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE; PubMed not MEDLINE

Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.

Authors: Kroenke MA Starcevic Manning M Zuch de Zafra CL et al.

Source: Frontiers in immunology [Front Immunol] 2024 Jan 26; Vol. 15, pp. 1345473. Date of Electronic Publication: 2024 Jan 26 (Print Publication: 2024).

Publication Type: Case Reports; Research Support, Non-U.S. Gov't; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Inhibition of RANKL is critical for accurate assessment of anti-drug antibody incidence to denosumab in clinical studies.

Authors: Miller MJ Kroenke MA Barger T et al.

Source: Journal of immunological methods [J Immunol Methods] 2025 May; Vol. 540, pp. 113864. Date of Electronic Publication: 2025 Apr 10.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1305440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7905 (Electronic) Linking ISSN: 00221759 NLM ISO Abbreviation: J Immunol Methods Subsets: MEDLINE

Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy.

Authors: Penny HL Hainline K Theoharis N et al.

Source: Frontiers in immunology [Front Immunol] 2023 Oct 23; Vol. 14, pp. 1261070. Date of Electronic Publication: 2023 Oct 23 (Print Publication: 2023).

Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions.

Authors: Zhou Y Zhang F Starcevic Manning M et al.

Source: Cephalalgia : an international journal of headache [Cephalalgia] 2022 Jul; Vol. 42 (8), pp. 749-760. Date of Electronic Publication: 2022 Mar 10.

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 8200710 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2982 (Electronic) Linking ISSN: 03331024 NLM ISO Abbreviation: Cephalalgia Subsets: MEDLINE

Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment.

Authors: Semple JW Schifferli A Cooper N et al.

Source: Blood reviews [Blood Rev] 2024 Sep; Vol. 67, pp. 101222. Date of Electronic Publication: 2024 Jun 20.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 8708558 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1681 (Electronic) Linking ISSN: 0268960X NLM ISO Abbreviation: Blood Rev Subsets: MEDLINE

Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target.

Authors: Kroenke MA Barger TE Hu J et al.

Source: Frontiers in immunology [Front Immunol] 2021 Dec 14; Vol. 12, pp. 782788. Date of Electronic Publication: 2021 Dec 14 (Print Publication: 2021).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Assessment of romiplostim immunogenicity in adult patients in clinical trials and in a global postmarketing registry.

Authors: Mytych DT Park JK Kim J et al.

Source: British journal of haematology [Br J Haematol] 2020 Sep; Vol. 190 (6), pp. 923-932. Date of Electronic Publication: 2020 Apr 20.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double-blind Study in Healthy Subjects.

Authors: Chow V Mytych DT Das S et al.

Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Sep; Vol. 12 (9), pp. 863-873. Date of Electronic Publication: 2023 Jul 07.

Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

A randomized, double-blind, single-dose, three-arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris^® ) in healthy male subjects.

Authors: Chow V Pan J Chien D et al.

Source: European journal of haematology [Eur J Haematol] 2020 Jul; Vol. 105 (1), pp. 66-74. Date of Electronic Publication: 2020 Apr 27.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

Clinical Immunogenicity Risk Assessment for a Fusion Protein.

Authors: Sperinde G Montgomery D Mytych DT

Source: The AAPS journal [AAPS J] 2020 Apr 03; Vol. 22 (3), pp. 64. Date of Electronic Publication: 2020 Apr 03.

Publication Type: Journal Article; Review

Journal Info: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology.

Authors: Zhou Y Penny HL Kroenke MA et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Apr; Vol. 10 (4).

Publication Type: Journal Article; Review

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE